Higher incidence of pegfilgrastim-induced bone pain in younger patients receiving myelosuppressive chemotherapy: a real-world experience

BACKGROUND: Pegfilgrastim is widely used for the prevention of febrile neutropenia (FN) in patients receiving myelosuppressive chemotherapy for various types of cancer. However, pegfilgrastim-induced bone pain (PIBP) is a relevant adverse event occurring during cancer treatment. Thus, we aimed to de...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuboi, Shinya, Hayama, Tatsuya, Miura, Katsuhiro, Uchiike, Akihiro, Tsutsumi, Daisuke, Yamauchi, Takashi, Hatta, Yoshihiro, Ootsuka, Susumu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832663/
https://www.ncbi.nlm.nih.gov/pubmed/36627672
http://dx.doi.org/10.1186/s40780-022-00272-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832663/
https://www.ncbi.nlm.nih.gov/pubmed/36627672
http://dx.doi.org/10.1186/s40780-022-00272-9

Ejemplares similares